Alexion Pharma acquisition of Synageva BioPharma

Overview:

• Alexion Pharma, a New Haven, Connecticut-based pharmaceuticals company, has acquired Synageva BioPharma, a Lexington, Massachusetts-based pharmaceuticals company, in a transaction worth $8.4 billion. 
• Lazard and JPMorgan acted as Alexion's financial advisers. 
• Goldman Sachs acted as Synageva's financial adviser. 
• Synageva delisted from the NASDAQ Global Market on June 22, 2015. 

Rani Mehta - Journalist